To evaluate the predictive capability of point-of-care bioactive adrenomedullin (bio-ADM) for bacteremia in patients with suspected severe infections in the emergency department, highlighting its potential impact on timely interventions.
Key Findings:
Bio-ADM levels were significantly associated with bacteremia in patients presenting with suspected severe infections, with a cut-off of > 45 pg/ml established for predicting bacteremia, indicating its potential as a reliable diagnostic tool.
Interpretation:
The findings suggest that bio-ADM could serve as a valuable biomarker for early identification of severe infections, potentially improving patient outcomes through timely intervention in emergency settings.
Limitations:
The study was limited by its small sample size and convenience sampling method, which may affect the generalizability of the results and should be addressed in future research.
Conclusion:
Bioactive adrenomedullin shows promise as a rapid biomarker for predicting bacteremia in emergency department patients with suspected severe infections, warranting further research to explore its clinical applications.
